Literature DB >> 7024317

Rapid identification of Corynebacterium vaginale in non-purulent vaginitis.

J I Wells, S H Goei.   

Abstract

A simple set of tests is proposed to give excellent probability for the identification of Corynebacterium vaginale from clinical material. Using these tests, 380 C vaginale were isolated from genital tract specimens from 1402 patients. Of these isolates 70 were from symptomatic patients. These 70 isolates were subjected to a further set of tests to confirm their identity. The advantage of these primary tests is that they can be completed on the day of isolation of the organism. Of these 70 isolates 66 were confirmed as C vaginale thus giving the primary set of tests a 94% rate of accurate identification. However this rate may be increased beyond 97% by the promotion of one of the key secondary tests to the primary set.

Entities:  

Mesh:

Year:  1981        PMID: 7024317      PMCID: PMC493982          DOI: 10.1136/jcp.34.8.917

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Hemophilus vaginalis vaginitis.

Authors:  H L GARDNER; C D DUKES
Journal:  Ann N Y Acad Sci       Date:  1959-11-18       Impact factor: 5.691

2.  Salient features of Haemophilus vaginalis.

Authors:  J R Greenwood; M J Pickett
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

3.  Method for isolation and identification of Corynebacterium vaginale (Haemophilus vaginalis).

Authors:  W E Dunkelberg; R Skaggs; D S Kellogg
Journal:  Appl Microbiol       Date:  1970-01

4.  New differential medium for the isolation of Corynebacterium vaginale.

Authors:  P A Mickelsen; L R McCarthy; M E Mangum
Journal:  J Clin Microbiol       Date:  1977-04       Impact factor: 5.948

5.  Detection of bacteriuria by luciferase assay of adenosine triphosphate.

Authors:  A Thore; S Anséhn; A Lundin; S Bergman
Journal:  J Clin Microbiol       Date:  1975-01       Impact factor: 5.948

6.  Inhibition of Corynebacterium vaginale by metronidazole.

Authors:  R F Smith; W E Dunkelberg
Journal:  Sex Transm Dis       Date:  1977 Jan-Mar       Impact factor: 2.830

7.  Factors affecting isolation and identification of Haemophilus vaginalis (Corynebacterium vaginale).

Authors:  R K Bailey; J L Voss; R F Smith
Journal:  J Clin Microbiol       Date:  1979-01       Impact factor: 5.948

8.  Corynebacterium vaginale (Haemophilus vaginalis) in women with leukorrhea.

Authors:  W E Josey; W J McKenzie; D W Lambe
Journal:  Am J Obstet Gynecol       Date:  1976-11-01       Impact factor: 8.661

9.  Quantitative bacteriology of the vaginal flora in vaginitis.

Authors:  M E Levison; I Trestman; R Quach; C Sladowski; C N Floro
Journal:  Am J Obstet Gynecol       Date:  1979-01-15       Impact factor: 8.661

10.  Corynebacterium vaginale and vaginitis: a controlled trial of treatment.

Authors:  M J Balsdon; G E Taylor; L Pead; R Maskell
Journal:  Lancet       Date:  1980-03-08       Impact factor: 79.321

  10 in total
  5 in total

Review 1.  An overview of the diagnosis and treatment of Gardnerella vaginalis and Bacteroides associated vaginitis.

Authors:  B M Jones; G R Kinghorn; B I Duerden
Journal:  Eur J Clin Microbiol       Date:  1982-10       Impact factor: 3.267

Review 2.  Gardnerella vaginalis and its clinical syndrome.

Authors:  M J Balsdon
Journal:  Eur J Clin Microbiol       Date:  1982-10       Impact factor: 3.267

3.  Comparison of microscopic and cultural findings in the diagnosis of Gardnerella vaginalis infection.

Authors:  D Milatovic; K Machka; R V Brosch; H J Wallner; I Braveny
Journal:  Eur J Clin Microbiol       Date:  1982-10       Impact factor: 3.267

4.  Use of a sodium polyanetholesulfonate disk for the identification of Gardnerella vaginalis.

Authors:  L G Reimer; L B Reller
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

Review 5.  Gardnerella vaginalis: characteristics, clinical considerations, and controversies.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.